Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 753-758, February 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kao, G. D.
Right arrow Articles by Muschel, R. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kao, G. D.
Right arrow Articles by Muschel, R. J.

Cyclin B1 Availability Is a Rate-limiting Component of the Radiation-induced G2 Delay in HeLa Cells1

Gary D. Kao, W. Gillies McKenna, Amit Maity, Kenneth Blank and Ruth J. Muschel2

Department of Radiation Oncology [G. D. K., W. G. M., A. M., K. B.], and Department of Pathology and Laboratory Medicine [R. J. M.], University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104

Irradiation of tumor cells results in a G2 delay, which has been postulated to allow DNA repair and cell survival. The G2 delay after irradiation is marked in HeLa and other cells by delayed expression of cyclin B1. To test whether this depression of cyclin B1 contributes to the G2 delay, we induced cyclin B1 expression in irradiated HeLa cells using a dexamethasone-inducible promoter. Induction of cyclin B1 after radiation abrogated the G2 delay by approximately doubling the rate at which the cells reentered mitosis, whereas dexamethasone itself had no effect. However, overexpression of cyclin B1 did not eliminate the G2 delay in irradiated cells. In unirradiated cells, overexpression of cyclin B1 had no effect on cell cycle progression. Confirmation that reduction of cyclin B1 levels would prolong G2 was provided using antisense oligonucleotides to cyclin B1. These results demonstrate that cyclin B1 levels control the length of the G2 delay following irradiation in HeLa cells but do not exclude additional mechanisms controlling the mitotic delay after irradiation.

1 This work was supported by NIH Grants GM 47439, CA 46830, and CA 51149, and American Cancer Society Faculty Research Award (to W. G. M.), and an American Society for Therapeutic Radiology and Oncology Fellowship (to G. D. K.). The flow cytometry facility was supported by the Lucille B. Markey Trust.

2 To whom requests for reprints should be addressed, at Department of Pathology and Laboratory Medicine, John Morgan Building, Room 269, University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104.

Received 10/17/96. Accepted 12/20/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Fan, K. M. Ahmed, M. C. Coleman, D. R. Spitz, and J. J. Li
Nuclear Factor-{kappa}B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells
Cancer Res., April 1, 2007; 67(7): 3220 - 3228.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Kim, K. Murphy, F. Liu, S. E. Parker, M. L. Dowling, W. Baff, and G. D. Kao
Caspase-Mediated Specific Cleavage of BubR1 Is a Determinant of Mitotic Progression
Mol. Cell. Biol., November 1, 2005; 25(21): 9232 - 9248.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Bucci, I. D'Agnano, D. Amendola, A. Citti, G. H. Raza, R. Miceli, U. De Paula, R. Marchese, S. Albini, A. Felsani, et al.
Myc Down-Regulation Sensitizes Melanoma Cells to Radiotherapy by Inhibiting MLH1 and MSH2 Mismatch Repair Proteins
Clin. Cancer Res., April 1, 2005; 11(7): 2756 - 2767.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Torgler, S. Jakob, E. Ontsouka, U. Nachbur, C. Mueller, D. R. Green, and T. Brunner
Regulation of Activation-induced Fas (CD95/Apo-1) Ligand Expression in T Cells by the Cyclin B1/Cdk1 Complex
J. Biol. Chem., September 3, 2004; 279(36): 37334 - 37342.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
E. A. Lee, M. K. Keutmann, M. L. Dowling, E. Harris, G. Chan, and G. D. Kao
Inactivation of the mitotic checkpoint as a determinant of the efficacy of microtubule-targeted drugs in killing human cancer cells
Mol. Cancer Ther., June 1, 2004; 3(6): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
G. D. Kao, W. G. McKenna, M. G. Guenther, R. J. Muschel, M. A. Lazar, and T. J. Yen
Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response
J. Cell Biol., March 31, 2003; 160(7): 1017 - 1027.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. A. Porter, I. H. Cukier, and J. M. Lee
Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis
Blood, March 1, 2003; 101(5): 1928 - 1933.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Chen, B. Shen, L. Xia, A. Khaletzkiy, D. Chu, J. Y. C. Wong, and J.-J. Li
Activation of Nuclear Factor {kappa}B in Radioresistance of TP53-inactive Human Keratinocytes
Cancer Res., February 1, 2002; 62(4): 1213 - 1221.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Fletcher, Y. Cheng, and R. J. Muschel
Abolishment of the Tyr-15 Inhibitory Phosphorylation Site on cdc2 Reduces the Radiation-induced G2 Delay, Revealing a Potential Checkpoint in Early Mitosis
Cancer Res., January 1, 2002; 62(1): 241 - 250.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X.-Y. Yin, L. Grove, N. S. Datta, K. Katula, M. W. Long, and E. V. Prochownik
Inverse Regulation of Cyclin B1 by c-Myc and p53 and Induction of Tetraploidy by Cyclin B1 Overexpression
Cancer Res., September 1, 2001; 61(17): 6487 - 6493.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
A. J. Janss, A. Maity, C.-B. Tang, R. J. Muschel, W. G. McKenna, L. Sutton, and P. C. Phillips
Decreased cyclin B1 expression contributes to G2 delay in human brain tumor cells after treatment with camptothecin
Neuro-oncol, January 1, 2001; 3(1): 11 - 21.
[Abstract] [PDF]


Home page
Clin. Cancer Res.Home page
R. J. Sleiman and B. W. Stewart
Early Caspase Activation in Leukemic Cells Subject to Etoposide-induced G2-M Arrest: Evidence of Commitment to Apoptosis Rather Than Mitotic Cell Death
Clin. Cancer Res., September 1, 2000; 6(9): 3756 - 3765.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
L. M. Knowles and J. A. Milner
Diallyl disulfide inhibits p34cdc2 kinase activity through changes in complex formation and phosphorylation
Carcinogenesis, June 1, 2000; 21(6): 1129 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Badie, J. E. Itzhaki, M. J. Sullivan, A. J. Carpenter, and A. C. G. Porter
Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells
Mol. Cell. Biol., April 1, 2000; 20(7): 2358 - 2366.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. K. MacLachlan, K. Somasundaram, M. Sgagias, Y. Shifman, R. J. Muschel, K. H. Cowan, and W. S. El-Deiry
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
J. Biol. Chem., January 28, 2000; 275(4): 2777 - 2785.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Downes, C. Bachrati, S. Devlin, M Tommasino, T. Cutts, J. Watson, I Rasko, and R. Johnson
Mammalian S-phase checkpoint integrity is dependent on transformation status and purine deoxyribonucleosides
J. Cell Sci., January 3, 2000; 113(6): 1089 - 1096.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Kao, W. G. McKenna, and R. J. Muschel
p34Cdc2 Kinase Activity Is Excluded from the Nucleus during the Radiation-induced G2 Arrest in HeLa Cells
J. Biol. Chem., December 3, 1999; 274(49): 34779 - 34784.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
W. R. Taylor, S. E. DePrimo, A. Agarwal, M. L. Agarwal, A. H. Schönthal, K. S. Katula, and G. R. Stark
Mechanisms of G2 Arrest in Response to Overexpression of p53
Mol. Biol. Cell, November 1, 1999; 10(11): 3607 - 3622.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. Yu, L. Orlandi, P. Wang, M. S. Orr, A. M. Senderowicz, E. A. Sausville, R. Silvestrini, N. Watanabe, H. Piwnica-Worms, and P. M. O'Connor
UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C Phosphatase
J. Biol. Chem., December 11, 1998; 273(50): 33455 - 33464.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
P. Jin, S. Hardy, and D. O. Morgan
Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage
J. Cell Biol., May 18, 1998; 141(4): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Curman, B. Cinel, D. E. Williams, N. Rundle, W. D. Block, A. A. Goodarzi, J. R. Hutchins, P. R. Clarke, B.-B. Zhou, S. P. Lees-Miller, et al.
Inhibition of the G2 DNA Damage Checkpoint and of Protein Kinases Chk1 and Chk2 by the Marine Sponge Alkaloid Debromohymenialdisine
J. Biol. Chem., May 18, 2001; 276(21): 17914 - 17919.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. F. Crawford and H. Piwnica-Worms
The G2 DNA Damage Checkpoint Delays Expression of Genes Encoding Mitotic Regulators
J. Biol. Chem., September 28, 2001; 276(40): 37166 - 37177.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.